24 Nov 2024
Leading innovation for patients with valvular heart disease
Sponsored by Edwards Lifesciences
Anchorperson:
S. Dawkins
Spokespersons:
R. Parma, N. Van Mieghem
Summary
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Learning Objectives
- To learn how latest generation of transcatheter heart valves can facilitate a contemporary lifetime management of patients with valvular heart diseases
- To discuss the latest clinical outcomes data showing how transcatheter heart valves technologies enhance the quality of patient care
- To appreciate how a portfolio of device options can be employed to treat a broad spectrum of valve anatomy